Active NF-KB-like transcription complexes are multimers consisting of one or two members of a family of proteins related to the c-Rel proto-oncoprotein. We protein (p105) and that p5O is derived from the N-terminal portion of p105, which contains the RH domain. The C-terminal portion of p105 contains several ankyrinlike repeats, which have been found in proteins including erythrocyte ankyrin, cell cycle control proteins in Saccharomyces cerevisiae, the transcription factor GABP3, and the IKBPI inhibitor proteins MAD-3 and pp40 (14, 24) . Neither the function nor the fate of the C-terminal portion of p105 is completely understood, but it may be involved in cytoplasmic retention (6), inhibition of DNA binding by p5O homodimers (25, 31), and/or transcription activation (40a). In addition, the C-terminal p105 sequences can be expressed from an alternatively spliced mRNA and can function as an IKB protein (IKBy) in vitro (25). Although the p49/plOO protein is also likely to be processed, other cellular Rel proteins (p65, c-Rel, RelB, and Dorsal) do not appear to be processed and contain strong transcription activation domains in their unique C-terminal sequences (8, 29, 43, 47, 50, 51, 56) .
(p115). Here we report that in vitro-produced p105 comigrates with p124 from v-Rel-transformed spleen cells and that p105 and p124 appear to be identical by partial proteolytic mapping with V8 protease. Furthermore, both p105 and p50 can complex directly with v-Rel and chicken c-Rel in vitro. However, in vitro association with p105 by v-Rel does not necessarily correlate with transformation, since one nontransforming v-Rel mutant can associate with p105 in vitro.
NF-KB was first identified as a transcription factor which bound to the decameric DNA sequence GGGACTlTCC, found in the enhancer of the mouse immunoglobulin K light-chain gene (58) . Although originally associated with lymphoid-specific genes, NF-KB-binding sites have now been identified in genes expressed in cells of lymphoid and nonlymphoid origin as well as many viral enhancers (reviewed in reference 1). The NF-KB complex that binds to the K light-chain enhancer is a heterodimer consisting of subunits of 50 kDa (p5O) and 65 kDa (p65) (62) .
It is now apparent that NF-KB-like complexes can consist of any two of a number of proteins related to the c-Rel proto-oncoprotein. The Rel family includes p5O/plO5, p49/ plOO, p65, c-Rel, RelB, the viral oncoprotein v-Rel, and the Drosophila melanogaster dorsal gene product (reviewed in references 18 and 19) . It is likely that all mammalian Rel proteins can form homo-and heterodimers that can bind sites that fall within the consensus sequence for a KB site (GGGRNNYYCC, where R is a purine, Y is a pyrimidine, and N is any nucleotide). However, there are also non-Rel proteins that can bind to this sequence (4, 15, 49) .
Rel proteins are related through a domain of approximately 300 to 350 amino acids (aa), called the Rel homology (RH) domain. The RH domain contains sequences responsible for DNA binding, dimerization, inhibitor binding, and nuclear localization. However, Rel proteins are generally unrelated in sequences C-terminal to the RH domain.
cDNAs for mouse and human NF-KB p5O have recently been characterized (7, 17, 32, 40) . The sequences of these cDNAs and biochemical evidence (16) reveal that the p5O subunit of NF-KB is a processed form of a 105-kDa precursor * Corresponding author.
protein (p105) and that p5O is derived from the N-terminal portion of p105, which contains the RH domain. The C-terminal portion of p105 contains several ankyrinlike repeats, which have been found in proteins including erythrocyte ankyrin, cell cycle control proteins in Saccharomyces cerevisiae, the transcription factor GABP3, and the IKBPI inhibitor proteins MAD-3 and pp40 (14, 24) . Neither the function nor the fate of the C-terminal portion of p105 is completely understood, but it may be involved in cytoplasmic retention (6) , inhibition of DNA binding by p5O homodimers (25, 31) , and/or transcription activation (40a) . In addition, the C-terminal p105 sequences can be expressed from an alternatively spliced mRNA and can function as an IKB protein (IKBy) in vitro (25) . Although the p49/plOO protein is also likely to be processed, other cellular Rel proteins (p65, c-Rel, RelB, and Dorsal) do not appear to be processed and contain strong transcription activation domains in their unique C-terminal sequences (8, 29, 43, 47, 50, 51, 56) .
NF-KB-like complexes are regulated, in part, by subcellular localization. For example, the pSO-p65 NF-KB complex is sequestered in the cytoplasm in an inactive form through the interaction of IKB with p65 (2, 3) . NF-KB can be induced to translocate to the nucleus by a wide variety of mitogens, cytokines, and other proliferation signals, which cause the dissociation of IKB from the pSO-p65 complex (reviewed in reference 57).
v-Rel, the oncoprotein of the avian retrovirus Rev-T, transforms avian lymphoid cells in vitro and in vivo (reviewed in references 19 and 46). v-Rel shows cell typespecific subcellular localization in that it is a nuclear protein in chicken embryo fibroblasts (CEF) and is found predominantly in the cytoplasm of v-Rel-transformed spleen cells (20, 45, 61) . In contrast, c-Rel is an exclusively cytoplasmic protein when overexpressed in CEF (10) . v-Rel is a trun-cated and mutated form of the proto-oncoprotein c-Rel; the most obvious alteration in v-Rel is the loss of 118 C-terminal aa that are involved in transcription activation by and cytoplasmic retention of c-Rel (10, 22, 29, 63) .
Both v-Rel and c-Rel exist in multiple complexes involving one or more cellular proteins in v-Rel-transformed spleen cells. v-Rel is found exclusively in high-molecular-weight complexes in both the nucleus and the cytoplasm of these cells (13, 33, 41, 60) . The cellular proteins complexed with v-Rel have apparent molecular masses (Mr) on sodium dodecyl sulfate-polyacrylamide gels (SDS-PAG) of approximately 124, 115, 70, 68, and 40 kDa. The 70-, 68-, and 40-kDa proteins have been identified as an avian heat shock protein (p70), c-Rel (p68), and an avian IKB (pp4O), respectively (14, 37, 60) . The identities of p124 and p115 have not been determined previously.
Kieran et al. (32) have shown that human p50 can dimerize with a truncated v-Rel protein in vitro. On the basis of this result and the size of the p50 precursor protein, we have previously suggested that one of the higher-Mr v-Rel-associated proteins could be the NF-KB p50 precursor protein p105 (18, 19 (8, 36, 52) .
Plasmid Sp6ChplO5 was used to produce in vitro-transcribed RNAs encoding p105 and p5O by using SP6 RNA polymerase (Promega). RNA encoding full-length p105 was produced after linearizing pSp6ChplO5 with XhoI; to express p5O (truncated form of p105), pSp6ChplO5 was linearized with NsiI and then treated with T4 DNA polymerase to remove the 3' overhang. RNA encoding v-Rel was produced in vitro from plasmid CG129 (a kind gift of C. Gelinas) as described elsewhere (9) . Plasmids for the in vitro expression of v-Rel mutants v-SPW (42) and dStu/Hinc (21) EMSAs. Electrophoretic mobility shift assays (EMSAs) were performed essentially as described previously (9) . Briefly, 4 ,ul of in vitro-translated protein was incubated with either 32P-end-labeled oligonucleotide containing the c-rel promoter KB site (GGGAAATTCC [9] ) or an EcoRI-HindIII restriction fragment from plasmid p7/25 containing the H2-KB site (GGGGATTCCCC [39] CAT assays. CEF were prepared and cultured as described previously (10) . Approximately 2 x 106 cells were transfected with both reporter and producer plasmids (indicated in the figure legends) by the dimethyl sulfoxide-Polybrene method (30) . Approximately 48 h after transfection, cells were harvested and lysed in 25 mM Tris (pH 7.4) by several cycles of freeze-thawing. Chloramphenicol acetyltransferase (CAT) activity in the lysates was determined as described previously (9, 47) and corresponds to the amount of radioactivity in the acetylated form of chloramphenicol compared with the total amount of radioactivity in the acetylated and nonacetylated forms of chloramphenicol. All CAT assay results were normalized to 1-galactosidase activity by including plasmid MSV-3gal in the transfection mixes (9, 47 TATAACAACATTA!TCAACATGAGAAATGACCTTTACCQGACCCCGCTGCACCTGGCAGTAATCACAAAGCAGGCAGAGGTGGTAGAAGACCTGCTGAAGGCTGGAGCAAATGTCAACCTT 2040 t v T u r A n n A n n T I l e A s n M e t A r g A s n A (11) and others (23, 44) . Briefly, immuno-5 mM MgCl2, 0.1 M NaCl, 1% Nonidet P-40, 0.5% SDS, 1% precipitated proteins were electrophoresed on a preparative aprotinin [Sigma] ) and immunoprecipitated with anti-v-Rel gel, and bands were excised from the gel. Gel slices were antiserum as described previously (20) .
soaked in equilibration buffer (1.25 M Tris [pH 6.8], 0.1% SDS,1 mM EDTA) containing 20% glycerol and stuffed into the wells of a 12.5% SDS-PAG. The gel slices were overlaid with a solution of equilibration buffer containing 10% glycerol and5 ng of V8 protease (Sigma). Samples were allowed to digest for 30 min with the power off after they had been electrophoresed into the stacking gel. The samples were then electrophoresed until the tracking dye reached the bottom of the gel. The gel was then dried, and an image was generated on a phosphorimager (Molecular Dynamics), or the gel was soaked in a solution of 1 M sodium salicylate, dried, and subjected to fluorography. Immunoprecipitation of in vitro-prepared proteins. In vitrotranslated proteins were diluted to 400 ,ul in lysis buffer and incubated with 2 to 5 pI of anti-v-Rel antiserum for 1 h to overnight on ice. Protein A-Sepharose was then added, and samples were incubated on ice for 1 h. The Sepharose beads were then washed five times with lysis buffer, and the immune complexes were removed from the beads by boiling in 2 x SDS-sample buffer (0.125 M Tris [pH 6.8], 20% glycerol, 10% 2-mercaptoethanol, 4 .6% SDS, 0.1% bromphenol blue). The proteins were then resolved by PAG electrophoresis (PAGE) on a 9% SDS-PAG. The gels were soaked in 1 M sodium salicylate and dried, and fluorography was done at -70°C.
Nucleotide sequence accession number. The sequence of the chicken p105 cDNA can be obtained from GenBank (accession number M86930).
RESULTS
Cloning and sequence analysis of a cDNA encoding the chicken NF-KB p5O precursor, p15. A CEF cDNA library was screened with a degenerate oligonucleotide corresponding to a highly conserved aa sequence found in the RH domain of all Rel proteins identified to date, as described in Materials and Methods. We isolated six clones that showed significant similarity to cDNAs for the human and mouse NF-KB p5O precursor proteins (7, 17, 32, 40) , and the largest of these cDNAs was characterized further. Figure 1 shows (Fig. 2) . To look more closely at the extent of homology between these proteins, we have divided the proteins into five regions: N terminus (NH2), RH, hinge, ankyrin repeat, and C terminus (COOH). As described above, the regions of highest sequence identity between chicken and mammalian p105 proteins are the RH domain and the ankyrin repeat domain, which are 93 and 78% identical, respectively, between chicken and mouse p105.
The percentages of identity of the N and C termini as well as the hinge region are much lower.
Characterization of the chicken p105 protein. To show that our cDNA clone encoded a functional KB site-binding protein, we performed EMSAs with in vitro-produced protein.
Full-length p105, a truncated version of p105, and full-length v-Rel were translated in wheat germ extracts, as shown in Fig. 3A . Truncated p105 corresponds to a protein of approximately 50 kDa (aa 1 to 414) and contains the entire RH domain. We then performed an EMSA with the in vitrotranslated proteins and a consensus KB site from the chicken c-rel promoter (9) . As shown in Fig. 3B , v-Rel and chicken p5O bound to the KB site. v-Rel produced a large smear, as has been seen previously by us and others (9, 26, 31) , whereas p5O produced a tightly shifted complex. The wildtype KB site-containing oligonucleotide competed for both v-Rel and p5O DNA binding; however, an unrelated oligonucleotide did not compete (Fig. 3B ). p5O and v-Rel also bound to the KB site from the mouse major histocompatibil- (17, 32) , full-length p105 did not bind to either KB site (data not shown); however, the amount of in vitro-produced p105 was consistently low in wheat germ extracts (see Fig.  3A ).
Like other Rel family proteins, both mouse and human p105 precursor proteins contain sequences in the C-terminal halves of the proteins that can function as transcription activation domains when fused to heterologous DNA-binding proteins (40a) . To determine whether the chicken p105 protein also contained a C-terminal activation domain, we constructed a GALA-plO5 fusion gene encoding aa 1 to 147 of GALA and aa 415 to 984 of chicken p105. Figure 3C shows the results of a CAT assay with extracts of CEF cotransfected with a CAT reporter plasmid containing GAL4-binding sites upstream of a minimal promoter and producer plasmids expressing GAL4 fusions to C-terminal mouse c-Rel aa (pSG3'Mc), C-terminal mouse p105 aa (pSG3'MplO5), C-terminal chicken p105 aa (pSG3'ChplO5), or GALA aa 1 to 147 by themselves (pSG424). Both mouse and chicken p105 Cterminal aa sequences (Fig. 3C, lanes 3 and 4) (12, 13, 33, 41, 60) . Since human NF-KB p5O has been shown to associate with a truncated v-Rel protein in vitro (32), we thought that one of these higher-Mr proteins could be chicken p105. The results in Fig. 4A show that in vitro-translated p105 comigrates with the larger (p124) protein present in an anti-v-Rel immunoprecipitate from v-Rel-transformed spleen cells.
To determine whether the p105 protein and the v-Relassociated protein (p124) were related, gel slices were subjected to partial proteolysis with V8 protease. The partial peptide maps of in vitro-prepared p105 were virtually indistinguishable from those of the v-Rel-associated protein (p124) from the immunoprecipitate, whereas the lower band (p115) did not show any obvious similarity to p105 (Fig. 4B) . Therefore, p105 appears to be identical to the previously described p124 v-Rel-associated protein.
To demonstrate that p105 interacts directly with v-Rel, we performed immunoprecipitation experiments with in vitrotranslated proteins (Fig. SA and B) . When v-Rel was cotranslated with p105 or p5O and immunoprecipitated with anti-Rel antiserum, bands corresponding to p105 (Fig. SB, lane 5) or p5O (Fig. SB, lane 8) were observed in addition to v-Rel. Neither preimmune serum nor anti-v-Rel antiserum recognized chicken p105 or p5O in these in vitro immunoprecipitation experiments. These results indicate that v-Rel complexed with p105 and p5O and that this complex was precipitated by the anti-v-Rel antiserum. Additionally, chicken c-Rel also formed complexes with p105 in vitro (Fig. SC) .
To determine whether mutations that abolish spleen cell transformation by v-Rel also affected association between v-Rel and p105, we assayed two nontransforming v-Rel proteins for their ability to associate with p105 in vitro. As shown in Fig. 6 , a nontransforming v-Rel protein with a 58-aa deletion near the end of the RH domain (dStu/Hinc [21] ) did not complex with p105 in vitro, but a nontransforming mutant with a 2-aa insertion in the RH domain (v-SPW [42] ) still associated with p105 in vitro.
The results presented in this section identify chicken p105
as one of the in vivo v-Rel-associated proteins. Furthermore, they demonstrate that v-Rel can associate with both the precursor and processed forms of chicken NF-KB p5O in vitro. However, the ability of v-Rel to associate with p105 is not precisely correlated with its transforming ability, since there is one nontransforming v-Rel mutant that can still associate with p105 in vitro. ) were excised from preparative SDS-PAGs and digested with 5 ng of V8 protease in a 12.5% SDS-PAG as described in Materials and Methods. The proteolytic fragments shared between p105 and p124 are indicated by the arrows to the left side of the picture. The image in lanes 1 and 2 was generated by phosphorimaging of the dried gel. The image in lanes 3 and 4 was generated by fluorography, and these samples were run on a different SDS-PAG than lanes 1 and 2, which is why the fragments in lanes 2 and 4 (in vitro-synthesized p105) do not match precisely. Sizes of molecular mass markers are also indicated to the right of the figure for lanes 3 and 4.
DISCUSSION
Sequence analysis of the chicken NF-KB p5O precursor p105. Sequence analysis of a cDNA encoding the chicken NF-KdB p5O precursor protein p105 reveals that chicken p105 is approximately 70% identical to mouse and human p105 proteins. Because of the high degree of sequence identity in the RH domain of p50 (93% identical between chicken and mouse), it is almost certain that the proteins from chickens and mammals would show virtually identical biochemical and cellular properties in vitro and in vivo. On the other hand, the RH domain of chicken p50 is only approximately 50% identical to chicken c-Rel and v-Rel. These differences~- may account for differences that are seen in the ability of p50 and c-Rel to recognize different KB half sites.
Chicken p50, like mammalian p5O, has additional sequences in the RH domain compared with other Rel proteins: there are three small insertions of 16 aa (aa 172 to 187), 13 aa (aa 198 to 210), and 5 aa (aa 292 to 296). The functional significance of these small insertions is not known. One possibility is that these insertions interfere with the ability of IKB to inhibit DNA binding by p5O; even though IKBB (pp4O) can interact with p5O, it does not prevent DNA binding by p5O homodimers as IKBt does with complexes containing other Rel family proteins, such as p65 and c-Rel (26a, 31). Another possibility is that these p50-specific sequences confer a transcription activation function on the RH domain of p50, since it has been shown that p50 homodimers can activate transcription in vivo as the factor known as KBF1 (27) .
Within the C-terminal portion of chicken p105 (aa 541 to 789), as in mammalian p105 proteins, there are six full ankyrinlike repeats followed by a seventh half repeat. (40a) . These types of results suggest that the C terminus of c-Rel is directly masking the nuclear localization signal and that cytoplasmic retention of c-Rel in CEF occurs through a mechanism that is independent of IKB association.
Cytoplasmic retention is probably not the only function for the C terminus of p105. That is, the C-terminal sequences of mouse p105 can specifically inhibit DNA binding of p50 homodimers (25, 31) . In addition, we have shown that chicken, mouse, and human p105 C-terminal aa have sequences that can function as a transcription activator when fused to the DNA-binding domain of GAL4 (40a) (Fig. 3C) . The transcription-activating function maps to the acidic aa located between the sixth and seventh ankyrin repeats in mouse p105 (40a) . Since these acidic aa are conserved in chicken p105, it is likely that these sequences are responsible for transcription activation by chicken C-terminal p105 sequences in SGCh3'plO5. Along these lines, it is interesting that ankyrinlike repeats have been found in a protein, GABPfi, known to be involved in transcription activation (35) . In similarity between p115 and p105 by partial V8 proteolysis mapping, it is unlikely that p115 is an alternate form of p124 (p105). It seems more reasonable to suspect that the p115 v-Rel-associated protein is the nonprocessed form of the p50/plO5-related protein p49/plOO (55) . v-Rel is an inactive version of the c-Rel protein in terms of transcription activation, and v-Rel can interfere with transcription activation by c-Rel and related proteins in a dominant-negative fashion (5, 26, 29, 47) . Although v-Rel can bind to DNA in vitro, the bulk of the data indicate that it is unlikely that v-Rel effects transformation by binding directly to DNA. First, the majority of v-Rel is located in the cytoplasm of v-Rel-transformed cells, and a v-Rel protein with a mutated nuclear localizing sequence is fully transforming and appears to be located exclusively in the cytoplasm of transformed spleen cells (21) . Second, since the overwhelming majority of v-Rel in transformed spleen cells is complexed with p105 (p124) or pp4O, it is unlikely that either of these forms is competent for DNA binding. That is, pp4O (IKB) inhibits KB site binding by complexes containing c-Rel (14) , and p105 does not bind to DNA (17, 32) . Still, there is some v-Rel in cells which can bind to DNA, since extracts from v-Rel-transformed spleen cells do contain KB site-binding activity that includes v-Rel (28) .
We favor a model for transformation in which v-Rel is disrupting the regulation of NF-KB complexes, through either the formation of altered Rel family protein heterodimers or the titration of an inhibitor such as pp40 (IKB). Our identification of avian NF-KB p105 as one of the v-Rel-associated proteins, our demonstration that v-Rel can complex with p50 in vitro, the characterization of dominantnegative mutants of p50 and c-Rel (26, 38, 47) , and our suggestion that the remaining unidentified v-Rel-associated protein p115 is likely to be the NF-KB p49/plOO precursor protein all support this type of model. This model would predict that multiple types of mutations could activate the transforming potential of c-Rel, and there is some evidence for this (22, 29) . Similarly, it would suggest that overexpression of mutant versions of other Rel family proteins would be transforming, provided that they could form the same types of cellular complexes as mutant c-Rel proteins. However, it is clear that association with p105 or pp4O is not sufficient for transformation, since v-SPW, a nontransforming v-Rel mutant, can still associate with p105 ( Fig. 6) , and both v-SPW and dStu/Hinc can associate with pp4O in vitro (8a). Furthermore, c-Rel associates with p105 and p40, yet c-Rel is not highly transforming when overexpressed in avian spleen cells (42) .
